Pharmacological treatment of tic disorders and Tourette Syndrome.
about
Antiepileptic drugs for Tourette's syndromeFunctional Evaluations of Genes Disrupted in Patients with Tourette's Disorder.Tetrabenazine: Spotlight on Drug Review.Animal models of tic disorders: a translational perspective.Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalonThe implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.Is There a Relationship Between Tic Frequency and Physiological Arousal? Examination in a Sample of Children With Co-Occurring Tic and Anxiety DisordersA Review and Update on Tourette Syndrome: Where Is the Field Headed?The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.Deconstructing 5-HT6 receptor effects on striatal circuit function.Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study.Pharmacologic treatment of obsessive-compulsive disorder comorbidity.Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders.What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome.Antipsychotic-induced hyperprolactinemia in Tourette syndrome.Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial.Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options.Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome.A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome: a randomized controlled trial.Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial.Deep TMS add-on treatment for intractable Tourette syndrome: A feasibility study.Pharmacotherapies to tics: a systematic review.
P2860
Q24186745-25213BBA-D91E-41FF-8CC1-19F9EE62D87CQ26768144-CE4F7C66-B0BD-4312-A098-E10208513C4AQ27692599-BDC6A0E6-F748-4765-AD54-FEFE11B72772Q30395243-6372B404-5952-49B9-8271-24A39408E21AQ30404423-20342C7F-7016-4662-A936-203A9E946B89Q30427160-55E7A35F-3D82-438B-8A17-3900701C917FQ34112026-7DC2A683-2985-4264-853F-56877AD93B77Q34244925-64B42F0B-5FB9-413B-8621-CFA4F0528B31Q34516696-26630760-1427-4D22-A8D7-0272D2E5524EQ35208541-B13A60B6-4E33-4302-9B90-FFDC753A44BAQ35688656-E20A15BD-0D93-42AF-8325-E6662D8AA926Q36906661-B3B4606C-9F36-46AC-A50D-8261F8D72C34Q37660848-83246050-172C-4C0C-B8F1-07BC2B0CFE39Q38254003-896F06AC-9D59-4D46-92C6-4737D2AADBB3Q38378640-92BD62FD-2797-4F76-BA2F-F3ED8971F760Q39035125-84B68495-AB95-4CC9-90C9-0182020DAC97Q39455909-10376F7F-E8CD-410E-BF28-E2417FFB26FEQ40972215-BA3CE6F5-6A11-4928-BCF1-4F7605F842C0Q42545583-7A84E702-1B5E-4C0A-99AC-F5BA6DE56586Q47559197-A984C654-661B-4D54-A83D-C4D0911C8FE6Q47965242-32845365-983E-45E3-956D-C02AE64F018BQ48114550-2EA67A2A-C912-4BA9-9989-D03595102C41Q50616608-D43A6A40-9927-4F46-9993-383FEE5A3FFEQ55365792-2839EB97-5109-4874-95B1-6CC54CCF168D
P2860
Pharmacological treatment of tic disorders and Tourette Syndrome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacological treatment of tic disorders and Tourette Syndrome.
@en
type
label
Pharmacological treatment of tic disorders and Tourette Syndrome.
@en
prefLabel
Pharmacological treatment of tic disorders and Tourette Syndrome.
@en
P2093
P1433
P1476
Pharmacological treatment of tic disorders and Tourette Syndrome.
@en
P2093
Judith Buse
Katja Schoenefeld
Stephan Bender
Veit Roessner
P304
P356
10.1016/J.NEUROPHARM.2012.05.043
P577
2012-06-20T00:00:00Z